Celldex Therapeutics
CLDX
CLDX
102 hedge funds and large institutions have $27.4M invested in Celldex Therapeutics in 2018 Q2 according to their latest regulatory filings, with 19 funds opening new positions, 21 increasing their positions, 37 reducing their positions, and 48 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
60% less first-time investments, than exits
New positions opened: 19 | Existing positions closed: 48
66% less call options, than puts
Call options by funds: $25K | Put options by funds: $74K
84% less capital invested
Capital invested by funds: $172M → $27.4M (-$145M)
Holders
102
Holding in Top 10
2
Calls
$25K
Puts
$74K
Top Buyers
| 1 | +$2.05M | |
| 2 | +$925K | |
| 3 | +$776K | |
| 4 |
Two Sigma Investments
New York
|
+$681K |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
+$461K |
Top Sellers
| 1 | -$17.9M | |
| 2 | -$13.9M | |
| 3 | -$3.28M | |
| 4 |
TA
Teachers Advisors
New York
|
-$2.35M |
| 5 |
Charles Schwab
San Francisco,
California
|
-$1.34M |